2017 News

12.25.2017 Information

CSR page on our website has been updated

12.21.2017 Press Release

Santen Receives Complete Response Letter from U.S. FDA for Intravitreal Sirolimus (DE-109)

11.27.2017 Press Release

Santen Files for Manufacturing and Marketing Approval of Glaucoma and Ocular Hypertension Drug Candidate DE-117 (JAN: Omidenepag Isopropyl)

11.01.2017 Press Release

Santen Announces Approval of Diquas for the Treatment of Dry Eye in China

11.01.2017 Press Release

Santen Reports the 2nd Quarter Fiscal 2017 Consolidated Performance

10.26.2017 Press Release

Santen to Participate in UN Global Compact

10.04.2017 Information

CSR page on our website has been updated

09.19.2017 Press Release

Santen Selected as a Member of Dow Jones Sustainability Asia Pacific Index, an Index for Socially Responsible Investment

09.01.2017 Press Release

Notice on Details of Subscription Rights to New Shares(Stock Options for Stock-Linked Remuneration)

08.01.2017 Press Release

Santen to Grant Subscription Rights to New Shares as Stock Options for Stock-Linked Remuneration

08.01.2017 Press Release

Santen Reports the 1st Quarter Fiscal 2017 Consolidated Performance

07.26.2017 Press Release

Santen and TRACON Announce Initiation of a Phase 2a Study of DE-122 for the Treatment of Wet Age-Related Macular Degeneration

07.26.2017 Press Release

Santen Receives Positive CHMP Opinion in Europe for Ciclosporin eye drops for the Treatment of Paediatric Patients with Severe Vernal Keratoconjunctivitis

07.18.2017 Press Release

Santen Donates to Northern Kyushu Area Disaster Relief Efforts

06.29.2017 Information

CSR page on our website has been updated

05.10.2017 Press Release

Santen Reports Fiscal 2016 Consolidated Performance

05.10.2017 Press Release

Notice of Board of Director and Corporate Auditor Nominations

05.01.2017 Press Release

Santen to Establish a Corporate Venture Capital Fund in the United States

04.25.2017 Press Release

Santen Announces U.S. FDA Filing Acceptance of New Drug Application (NDA) for Intravitreal Sirolimus (DE-109) in the Treatment of NIU-PS

04.07.2017 Press Release

Santen Announces Strategic Investment in Regenerative Patch Technologies LLC

04.05.2017 Information

CSR page on our website has been updated

03.16.2017 Press Release

Santen and Japan Blind Football Association (JBFA) Enter Partnership

03.15.2017 Press Release

Notice of Corporate Officer Appointments

03.02.2017 Press Release

SANTEN AND SINGAPORE EYE RESEARCH INSTITUTE (SERI) ANNOUNCE AN EXPANDED RELATIONSHIP INCLUDING THE CREATION OF A NEW JOINT LABORATORY TO DEVELOP NOVEL OPHTHALMIC THERAPEUTICS, DIAGNOSTICS AND DEVICES

02.22.2017 Press Release

Santen to Cosponsor "Light Up in Green" Campaign during World Glaucoma Week from March 12 to 18, 2017

02.09.2017 Information

Voice conference on the Financial Result of the 3rd Quarter of FY2016

02.07.2017 Press Release

Santen Reports the 3rd Quarter Fiscal 2016 Consolidated Performance

01.10.2017 Information

Presentation materials for the 35th Annual J.P.Morgan Healthcare Conference